Huakang Biomedical Holdings Company Limited (8622) Income Statement

Last quarter (Q2 2025), Huakang Biomedical Holdings Company Limited's total revenue was ¥6.16M, an increase of 3.45% from the same quarter last year. In Q2, Huakang Biomedical Holdings Company Limited's net income was ¥-1.18M. See Huakang Biomedical Holdings Company Limited’s key income statements, including revenue, expenses, profit, and income.